Internal Medicine, Hematology & Oncology · Plantation, FL
NPI
1679561294
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
8200 W Sunrise Blvd Bldg C
Plantation, FL, 33322
Phone (954) 370-8585
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
121,999 services
Medicare patients, 2024
348
Average age 75
Drug cost, 2024
$7.4M
2,245 prescriptions
Company payments, 2025
$913
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason Tache was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 45,000 times for 23 patients. In total Jason Tache billed 121,999 services in 95 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 45,000 | 23 | $2.33 | $105K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,195 | 33 | $0.09 | $197 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,300 | 11 | $15.93 | $21K |
| 85025 Blood Count | Office | 1,092 | 270 | $7.49 | $8,181 |
| 99213 Office E&M - Established | Office | 353 | 190 | $73.69 | $26K |
| 96367 Intravenous Infusion, Hydration | Office | 279 | 37 | $23.68 | $6,607 |
| 96372 Injection Administration | Office | 278 | 42 | $12.06 | $3,353 |
| 99214 Office E&M - Established | Office | 224 | 117 | $100.95 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 200 | 67 | $100.68 | $20K |
| 96413 Chemotherapy Administration | Office | 169 | 30 | $107.12 | $18K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 135 | 32 | $0.64 | $86.52 |
| J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 94 | 16 | $543.49 | $51K |
| 96365 Intravenous Infusion, Hydration | Office | 90 | 38 | $51.39 | $4,625 |
| 36415 Venipuncture Blood Collection | Office | 71 | 56 | $8.65 | $614 |
| 96415 Chemotherapy Administration | Office | 49 | 12 | $23.77 | $1,165 |
By year: 2022 $1.0M for 108,358 services; 2023 $1.1M for 99,660 services; 2024 $1.7M for 121,999 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,092 | 270 | $7.49 | $8,181 |
| 36415 Venipuncture Blood Collection | 71 | 56 | $8.65 | $614 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason Tache prescribed most often to Medicare patients was Eliquis (Apixaban), with 272 prescriptions and refills. In total Jason Tache wrote 2,245 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 272 | 343 | 58 | $198K |
| Ondansetron Odt Ondansetron | 99 | 100 | 58 | $2,411 |
| Hydroxyurea Generic | 97 | 166 | 22 | $2,769 |
| Anastrozole Generic | 96 | 195 | 23 | $1,299 |
| Acyclovir Generic | 73 | 86 | 16 | $542 |
| Pantoprazole Sodium Generic | 62 | 116 | 21 | $367 |
| Montelukast Sodium Generic | 58 | 102 | 17 | $268 |
| Xarelto Rivaroxaban | 57 | 82 | 11 | $44K |
| Lenalidomide Generic | 50 | 50 | Under 11 | $747K |
| Jakafi Ruxolitinib Phosphate | 46 | 46 | Under 11 | $737K |
| Clopidogrel Clopidogrel Bisulfate | 45 | 81 | Under 11 | $164 |
| Cyproheptadine Hcl Generic | 42 | 54 | 22 | $1,232 |
| Dexamethasone Generic | 42 | 58 | 21 | $944 |
| Folic Acid Generic | 42 | 67 | Under 11 | $101 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 39 | 39 | Under 11 | $52K |
Brand drugs: - claims; generic drugs: 1,352 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason Tache $913 ($913 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $197 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $114 |
| Pfizer Inc. PFE | 4 | $86.57 |
| Taiho Oncology, Inc. 4578.T | 3 | $70.14 |
| Merck Sharp & Dohme LLC MRK | 2 | $52.02 |
| Incyte Corporation INCY | 2 | $48.94 |
| SpringWorks Therapeutics, Inc. | 2 | $46.68 |
| Eisai Inc. 4523.T | 2 | $41.38 |
| GlaxoSmithKline, LLC. GSK | 1 | $30.69 |
| Daiichi Sankyo Inc. 4568.T | 1 | $27.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.